Found: 500
Select item for more details and to access through your institution.
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 709, doi. 10.1007/s40744-024-00668-z
- By:
- Publication type:
- Article
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 737, doi. 10.1007/s40744-024-00671-4
- By:
- Publication type:
- Article
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 3, p. 444, doi. 10.1093/mr/road055
- By:
- Publication type:
- Article
Post hoc analysis of patients with rheumatoid arthritis under clinical remission in two Japanese Phase 3 trials of peficitinib treatment (RAJ3 and RAJ4).
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 3, p. 453, doi. 10.1093/mr/road059
- By:
- Publication type:
- Article
Physician approval for pregnancy in patients with systemic lupus erythematosus showing only serological activity: A vignette survey study.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 3, p. 509, doi. 10.1093/mr/road049
- By:
- Publication type:
- Article
Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 3, p. 530, doi. 10.1093/mr/road068
- By:
- Publication type:
- Article
Neutrophil extracellular trap induction through peptidylarginine deiminase 4 activity is involved in 2,4,6-trinitrobenzenesulfonic acid-induced colitis.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, v. 397, n. 5, p. 3127, doi. 10.1007/s00210-023-02800-2
- By:
- Publication type:
- Article
Inflammatory Cytokines and Chemokines Are Synergistically Induced in a ROS-Dependent Manner by a Co-Culture of Corneal Epithelial Cells and Neutrophil-like Cells in the Presence of Particulate Matter.
- Published in:
- Antioxidants, 2024, v. 13, n. 4, p. 467, doi. 10.3390/antiox13040467
- By:
- Publication type:
- Article
Population Pharmacokinetics of Ozoralizumab in Patients with Rheumatoid Arthritis.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 4, p. 418, doi. 10.1002/jcph.2380
- By:
- Publication type:
- Article
Comparative effects of fixed‐dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 4, p. 449, doi. 10.1111/jdi.14138
- By:
- Publication type:
- Article
Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease.
- Published in:
- Rheumatology, 2024, v. 63, n. 4, p. 1068, doi. 10.1093/rheumatology/kead341
- By:
- Publication type:
- Article
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis.
- Published in:
- Journal of Bone & Mineral Metabolism, 2024, v. 42, n. 2, p. 143, doi. 10.1007/s00774-024-01502-w
- By:
- Publication type:
- Article
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases.
- Published in:
- Rheumatology, 2024, v. 63, n. 2, p. 298, doi. 10.1093/rheumatology/kead448
- By:
- Publication type:
- Article
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Correction: Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Validation of claims‐based algorithms for rheumatoid arthritis in Japan: Results from the VALIDATE‐J study.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 1, p. 1, doi. 10.1111/1756-185X.15001
- By:
- Publication type:
- Article
Socioeconomic impact of treatment with biological disease–modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 1, p. 27, doi. 10.1093/mr/roac160
- By:
- Publication type:
- Article
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 1, p. 37, doi. 10.1093/mr/road004
- By:
- Publication type:
- Article
Long-term evaluation of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 1, p. 45, doi. 10.1093/mr/road005
- By:
- Publication type:
- Article
Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 1, p. 87, doi. 10.1093/mr/roac152
- By:
- Publication type:
- Article
Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 1, p. 201, doi. 10.1093/mr/road026
- By:
- Publication type:
- Article
Infections Associated with Systemic Lupus Erythematosus: Tackling Two Devils in the Deep Blue Sea.
- Published in:
- Indian Journal of Rheumatology, 2023, v. 18, p. S3, doi. 10.4103/injr.injr_78_22
- By:
- Publication type:
- Article
Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 12, p. 2733, doi. 10.1093/ndt/gfad167
- By:
- Publication type:
- Article
Prevention of Radiographic Progression in Higher-Risk Patients with Rheumatoid Arthritis Using Filgotinib in Phase III Studies: Narrative Review of Post Hoc Analyses.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1399, doi. 10.1007/s40744-023-00590-w
- By:
- Publication type:
- Article
Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1555, doi. 10.1007/s40744-023-00599-1
- By:
- Publication type:
- Article
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1705, doi. 10.1007/s40744-023-00603-8
- By:
- Publication type:
- Article
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1795, doi. 10.1007/s40744-023-00593-7
- By:
- Publication type:
- Article
Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 6, p. 1145, doi. 10.1093/mr/roac122
- By:
- Publication type:
- Article
Validity of claims-based diagnoses for infectious diseases common among immunocompromised patients in Japan.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08466-8
- By:
- Publication type:
- Article
Treatment pattern and changes in oral glucocorticoid dose after tocilizumab treatment in patients with adult Still's disease: An analysis of a Japanese claims database.
- Published in:
- International Journal of Rheumatic Diseases, 2023, v. 26, n. 10, p. 1967, doi. 10.1111/1756-185X.14848
- By:
- Publication type:
- Article
Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 2499, doi. 10.2147/PPA.S417677
- By:
- Publication type:
- Article
Computed tomography for malignancy screening in patients with rheumatoid arthritis before initiation of disease modifying antirheumatic drug.
- Published in:
- Rheumatology, 2023, v. 62, n. 10, p. 3339, doi. 10.1093/rheumatology/kead075
- By:
- Publication type:
- Article
Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus.
- Published in:
- Rheumatology, 2023, v. 62, n. 10, p. 3490, doi. 10.1093/rheumatology/kead091
- By:
- Publication type:
- Article
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1255, doi. 10.1007/s40744-023-00576-8
- By:
- Publication type:
- Article
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1335, doi. 10.1007/s40744-023-00583-9
- By:
- Publication type:
- Article
Infections associated with systemic lupus erythematosus: Tackling two devils in the deep blue sea.
- Published in:
- Indian Journal of Rheumatology, 2023, v. 26, n. 11, p. 3, doi. 10.4103/injr.injr_78_22
- By:
- Publication type:
- Article
Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 5, p. 857, doi. 10.1093/mr/roac140
- By:
- Publication type:
- Article
Efficacy and safety of anti-TNF multivalent NANOBODY® compound 'ozoralizumab' without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, randomised, open-label trial (NATSUZORA trial).
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 5, p. 875, doi. 10.1093/mr/roac126
- By:
- Publication type:
- Article
Efficacy and safety of the anti-TNF multivalent NANOBODY(r) compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: A 52-week result of a Phase II/III study (OHZORA trial).
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 5, p. 883, doi. 10.1093/mr/roac119
- By:
- Publication type:
- Article
Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post‐hoc analysis of clinical trials.
- Published in:
- International Journal of Rheumatic Diseases, 2023, v. 26, n. 7, p. 1248, doi. 10.1111/1756-185X.14699
- By:
- Publication type:
- Article
A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4527, doi. 10.3390/jcm12134527
- By:
- Publication type:
- Article
Subcutaneous injection of methotrexate: Advantages in the treatment of rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 4, p. 633, doi. 10.1093/mr/roac156
- By:
- Publication type:
- Article
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 4, p. 657, doi. 10.1093/mr/roac083
- By:
- Publication type:
- Article
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 4, p. 668, doi. 10.1093/mr/roac084
- By:
- Publication type:
- Article
Efficacy and tolerability of subcutaneously administered methotrexate including dose escalation in long-term treatment of rheumatoid arthritis in a Japanese population.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 4, p. 680, doi. 10.1093/mr/roac103
- By:
- Publication type:
- Article
TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus.
- Published in:
- Rheumatology, 2023, v. 62, n. 7, p. 2464, doi. 10.1093/rheumatology/keac646
- By:
- Publication type:
- Article
Evaluation of asymptomatic cerebral ischemia by arterial spin-labeling magnetic resonance imaging of the brain in Takayasu arteritis.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 6, p. 960, doi. 10.3390/biom13060960
- By:
- Publication type:
- Article
Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 539, doi. 10.1007/s40744-022-00521-1
- By:
- Publication type:
- Article
Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 693, doi. 10.1007/s40744-023-00541-5
- By:
- Publication type:
- Article